2012 Bonus and 2013 Compensation Schedule for Named Executive Officers
This document outlines the 2012 bonus payments and 2013 compensation details for the company's named executive officers, including the President and CEO, CFO, and other senior executives. It specifies each executive's 2012 bonus, 2013 base salary, target bonus as a percentage of salary, and the number of stock options to be granted. The agreement sets forth the key financial terms of executive compensation for the specified years.
Exhibit 10.1
2012 Bonus and 2013 Compensation Information for Named Executive Officers
| Name | Title | 2012 Bonus | 2013 Base Salary | 2013 Target Bonus (% of Salary) | Stock Options | |||||||||||||
| Robert I. Blum | President and Chief Executive Officer | $ | 242,813 | $ | 555,000 | 50 | % | 800,000 | ||||||||||
| Sharon A. Barbari | Executive Vice President, Finance and Chief Financial Officer | $ | 139,783 | $ | 391,000 | 40 | % | 300,000 | ||||||||||
| David W. Cragg | Senior Vice President, Human Resources | $ | 73,496 | $ | 278,000 | 30 | % | 150,000 | ||||||||||
| Fady I. Malik | Senior Vice President, Research and Early Development | $ | 83,119 | $ | 355,000 | 30 | % | 300,000 | ||||||||||
| Andrew A. Wolff | Senior Vice President, Clinical Research and Development and Chief Medical Officer | $ | 117,976 | $ | 388,000 | 35 | % | 250,000 | ||||||||||
